Structural characterization of the ectodomain of a disintegrin and metalloproteinase-22 (ADAM22), a neural adhesion receptor instead of metalloproteinase: insights on ADAM function.
ADAMs (a disintegrin and metalloproteinases) are a family of multidomain transmembrane glycoproteins with diverse roles in physiology and diseases, with several members being drug targets for cancer and inflammation therapies. The spatial organization of the ADAM extracellular segment and its influence on the function of ADAMs have been unclear. Although most members of the ADAM family are active zinc metalloproteinases, 8 of 21 ADAMs lack functional metalloproteinase domains and are implicated in protein-protein interactions instead of membrane protein ectodomain shedding. One of such non-proteinase ADAMs, ADAM22, acts as a receptor on the surface of the postsynaptic neuron to regulate synaptic signal transmission. The crystal structure of the full ectodomain of mature human ADAM22 shows that it is a compact four-leaf clover with the metalloproteinase-like domain held in the concave face of a rigid module formed by the disintegrin, cysteine-rich, and epidermal growth factor-like domains. The loss of metalloproteinase activity is ensured by the absence of critical catalytic residues, the filling of the substrate groove, and the steric hindrance by the cysteine-rich domain. The structure, combined with calorimetric experiments, suggests distinct roles of three putative calcium ions bound to ADAM22, with one in the metalloproteinase-like domain being regulatory and two in the disintegrin domain being structural. The metalloproteinase-like domain contacts the rest of ADAM22 with discontinuous, hydrophilic, and poorly complemented interactions, suggesting the possibility of modular movement of ADAM22 and other ADAMs. The ADAM22 structure provides a framework for understanding how different ADAMs exert their adhesive function and shedding activities.
Liu
Heli
H
Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.
Shim
Ann H R
AH
He
Xiaolin
X
D051722:ADAM Proteins / Q000737:chemistry*; D000595:Amino Acid Sequence; D000818:Animals; D002151:Calorimetry / Q000379:methods; D015816:Cell Adhesion Molecules, Neuronal / Q000378:metabolism*; D003545:Cysteine / Q000737:chemistry; D019281:Dimerization; D006801:Humans; D007313:Insecta; D045726:Metalloproteases / Q000737:chemistry*; D008958:Models, Molecular; D008968:Molecular Conformation; D008969:Molecular Sequence Data; D009419:Nerve Tissue Proteins / Q000737:chemistry*; D010455:Peptides / Q000737:chemistry; D017434:Protein Structure, Tertiary
D015816:Cell Adhesion Molecules, Neuronal; D009419:Nerve Tissue Proteins; D010455:Peptides; D045726:Metalloproteases; D051722:ADAM Proteins; C498474:ADAM22 protein, human; D003545:Cysteine
Mol Aspects Med. 2008 Oct;29(5):258-89
18762209
Nat Rev Neurosci. 2004 May;5(5):400-8
15100722
Int J Biol Sci. 2008;4(6):387-96
18974846
FEBS Lett. 2007 May 29;581(13):2416-22
17485084
J Biol Chem. 2002 Jul 19;277(29):26403-11
12000744
Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3408-12
9520379
J Mol Biol. 2004 Jan 2;335(1):129-37
14659745
Thromb Haemost. 2003 Apr;89(4):622-31
12669115
Biochemistry. 2008 Jan 15;47(2):537-47
18081311
J Biol Chem. 2008 Jan 18;283(3):1501-1507
17991750
J Clin Neurosci. 2004 Apr;11(3):227-35
14975408
Pharmacol Ther. 2006 Sep;111(3):985-1006
16626807
Trends Genet. 2000 Feb;16(2):83-7
10652535
J Biol Chem. 1999 May 7;274(19):13427-33
10224107
Biophys J. 1999 Apr;76(4):1856-67
10096884
Biochimie. 2008 Feb;90(2):369-79
17920749
Science. 2006 Sep 22;313(5794):1792-5
16990550
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W375-83
17452350
Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):905-21
9757107
Genes Dev. 2003 Jan 1;17(1):7-30
12514095
FEBS Lett. 1993 Sep 27;331(1-2):134-40
8405391
J Biol Chem. 2009 Jun 5;284(23):15353-7
19201757
Curr Opin Cell Biol. 2003 Oct;15(5):598-606
14519395
Methods Enzymol. 1997;276:307-26
27754618
Cardiovasc Hematol Agents Med Chem. 2007 Jan;5(1):29-42
17266546
Semin Cell Dev Biol. 2009 Apr;20(2):164-74
18951988
Protein Expr Purif. 2008 Oct;61(2):175-83
18593599
Biochem J. 2005 May 1;387(Pt 3):797-805
15581423
Biochemistry. 2004 Jun 15;43(23):7227-35
15182168
Protein Sci. 2008 Jan;17(1):16-21
18042673
Gene. 1999 Aug 5;236(1):79-86
10433968
J Mol Biol. 2007 Nov 2;373(4):891-902
17897672
Science. 2006 Mar 3;311(5765):1253-6
16513974
J Mol Biol. 1993 Dec 20;234(4):946-50
8263940
FEBS Lett. 2007 Dec 22;581(30):5859-64
18060879
J Biol Chem. 2006 Apr 7;281(14):9418-22
16455653
Cell. 2005 Oct 21;123(2):291-304
16239146
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
15572765
EMBO J. 2006 Jun 7;25(11):2388-96
16688218
Mol Biotechnol. 2003 Jun;24(2):157-202
12746556
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
19461840
BMC Neurosci. 2005 May 06;6:33
15876356